![Harish Shantharam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Harish Shantharam
Financieel Directeur/CFO bij
ALX ONCOLOGY HOLDINGS INC.
Vermogen: 151 320 $ op 31-07-2026
Profiel
Harish Shantharam currently works at ALX Oncology Holdings, Inc., as Chief Financial Officer from 2025.
Mr. Shantharam also formerly worked at CymaBay Therapeutics, Inc., as Chief Financial & Accounting Officer in 2024, Gilead Sciences, Inc., as Vice President-Global Commercial Finance from 2011 to 2022, and Amgen, Inc., as Head-Business Development from 2004 to 2011.
Mr. Shantharam received his graduate degree from The University of Texas at Arlington and Masters Business Admin degree from UCLA Anderson School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 78.000 ( 0,06% ) | 151 320 $ | 31-07-2026 |
Actieve functies van Harish Shantharam
| Bedrijven | Functie | Begin |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Financieel Directeur/CFO | 21-01-2025 |
Eerdere bekende functies van Harish Shantharam
| Bedrijven | Functie | Einde |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Financieel Directeur/CFO | 22-03-2024 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-05-2022 |
| AMGEN INC. | Corporate Officer/Principal | 01-11-2011 |
Opleiding van Harish Shantharam
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
86
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
The University of Texas at Arlington
 The University of Texas at Arlington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
